POM-V Prescription Required

NEMOVAC Lyophilisate for Oculonasal Suspension/use in Drinking Water

Active ingredient: Avian pneumovirus

Form

Liquid

Species

Chickens

Manufacturer

Boehringer Ingelheim Animal Health UK Ltd

VMD MA No.

08327/5008

What it's used for

For broiler chickens: For active immunisation of chickens between 7 and 14 days to reduce upper respiratory signs associated with avian pneumovirus infecti...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Avian pneumovirus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

NEMOVAC Lyophilisate for Oculonasal Suspension/use in Drinking Water — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For broiler chickens:
For active immunisation of chickens between 7 and 14 days to reduce upper respiratory
signs associated with avian pneumovirus infection (Swollen Head Syndrome).
Onset of immunity: 17 days after vaccination.
Duration of immunity: 3 weeks after vaccination.
For breeder and layer pullets:
Priming for active immunisation of pullets from 14 weeks of age before booster vaccination
with an inactivated vaccine containing avian pneumovirus to reduce respiratory signs
associated with avian pneumovirus infection.
For onset of immunity and duration of immunity of full schedule, see SPC of the inactivated
booster vaccine.

None

Amended pages: May 2024
AN: 02222/2023Page 2 of 5

None known.
In layer and breeder pullets, refer to the SPC of the inactivated booster vaccine.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See also the last section of the package leaflet for respective
contact details.

Vaccinate healthy animals only

Special precautions for use in animals:
The product is a live vaccine and is excreted from vaccinated birds and so spreads to
unvaccinated chickens and turkeys. Reversion to virulence trials carried out in the
laboratory have shown that the strain does not revert to virulence neither in chickens nor in
turkeys. However, precautionary measures have to be followed in order to diminish the
spread, see 4.5, 4.9, and 6.6.
It is advised not to vaccinate in the presence of other sensitive species (guinea fowl,
pheasant), taking into account the spread of the vaccine strain and the lack of safety data
for these species.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Care should be taken during reconstitution and administration of the vaccine.
Wash hands and wear disposable gloves during reconstitution and administration of the
vaccine.
Hands should be washed and disinfected after vaccinating.
Special precautions for the protection of the environment:
Not applicable.

Safety and efficacy data are available which demonstrate that the simultaneous use of the
vaccine and Infectious Bursal Disease, Infectious Bronchitis and Newcastle Disease
vaccines may slightly decrease or transiently delay the humoral response of animals to
NEMOVAC. The simultaneous use of the vaccine and Infectious Bronchitis vaccine may
decrease and/or delay the Infectious Bronchitis seroconversion. Therefore, no other
vaccine should be used simultaneously with the product.

Amended pages: May 2024
AN: 02222/2023Page 3 of 5

Store and transport refrigerated (2 °C – 8 °C)
Protect from light.
Do not freeze.
After reconstitution, do not store above 25°C.
Broached vials should not be stored

Zero days

Amended pages: May 2024
AN: 02222/2023Page 4 of 5
5. IMMUNOLOGICAL PROPERTIES

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.